Page 187 - Read Online
P. 187

Lai et al. Neuroimmunol Neuroinflammation 2017;4:179-87          Neuroimmunology and
           DOI: 10.20517/2347-8659.2017.29
                                                                                  Neuroinflammation

                                                                                                www.nnjournal.net
            Original Article                                                                    Open Access

           Peripheral NK and B regulatory cell frequencies

           are altered with symptomatic exacerbation in

           generalized myasthenia gravis patients



                      1,2
                                                                           2
                                                   1
                                                             3
                                    1
                                             1
           Xiao-Yin Lai , Meng-Cui Gui , Jing Lin , Yue Li , Xuan Luo , Long-Xuan Li , Bi-Tao Bu 1
           1 Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei, China.
           2 Department of Neurology, Gongli Hospital, Pudong New Area, Shanghai 200135, China.
           3 Teaching and Research Office of Hygiene, 95890 Unit, Chinese People's Liberation Army, Wuhan 430000, Hubei, China.
           Correspondence to: Dr. Bi-Tao Bu, Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and
           Technology, 1095 Jiefang Ave., Wuhan 430030, Hubei, China. E-mail: bubitao@tjh.tjmu.edu.cn; Dr. Long-Xuan Li, Department of Neurology, Gongli
           Hospital, 219 Miaopu Road, Pudong New Area, Shanghai 200135, China. E-mail: Longxuanlee2006@yahoo.com
           How to cite this article: Lai XY, Gui MC, Lin J, Li Y, Luo X, Li LX, Bu BT. Peripheral NK and B regulatory cell frequencies are altered with
           symptomatic exacerbation in generalized myasthenia gravis patients. Neuroimmunol Neuroinflammation 2017;4:179-87.
                          Dr. Bi-Tao Bu is a professor of Neurology Department, Tongji Hospital, Huazhong University of Science and
                          Technology (HUST) in China. He had been educated at Hunan Medical College and Tongji Medical College of
                          HUST respectively. He also had been trained at University of Washington for 2 years and at University of California
                          at Davies for 1 year. He has been devoted to the clinical and basic studies on myasthenia gravis, inflammatory
                          myopathies and neuromyelitis optica spectrum disorder. His study has been sponsored by Natural Science
                          Foundation of China and Sino-German Joint Education Foundation. He is the member of Chinese Medical Society,
                          Chinese Immunology Society, and American Society for Neurosciences.

                          Dr. Long-Xuan Li currently serves as the professor and director in the Department of Neurology in Gongli Hospital,
                          Shanghai. He is the Doctoral Supervisor of The Second Military Medical University and was awarded with the
                          100-Talents Program of the Shanghai Municipal Health Bureau in 2017. He graduated with a doctorate degree in
                          Tongji Medical College of Huazhong University of Science and Technology in 2003, and further got postdoctoral
                          trainings at VA Medical Center of Kansas City, MO and the Scripps Research Institute, CA during 2006-2010.
                          He also got clinical training at Cleveland Clinic, OH in 2015, and worked as a Visiting Scholar at Mayo Clinic,
                          FL in 2017. He has nearly twenty years of experiences in practicing clinical neurology with focus on stroke and
                          neurodegenerative diseases.
                                         ABSTRACT

            Article history:              Aim: Myasthenia gravis (MG)  is an autoimmune  disease, in which immunotherapy  can
            Received: 20 Jun 2017         improve symptoms for a period, but the majority of patients still experience symptomatic
            Accepted: 24 Jul 2017         fluctuation or develop myasthenic crisis. This study aimed to explore the relationship between
            Published: 18 Sep 2017        frequency of peripheral lymphocyte subsets and myasthenia gravis disease stage. Methods:
                                          The percentages of B regulatory (Breg) cells and natural killer (NK) cells in the peripheral


                                                                                              Quick Response Code:
                       This is an open access article distributed under the terms of the Creative Commons Attribution-
                       NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work
            non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.


            For reprints contact: service@oaepublish.com

                        © 2017 OAE Publishing Inc.  www.oaepublish.com                                    179
   182   183   184   185   186   187   188   189   190   191   192